Topical rather than intradermal application of the TLR7 ligand imiquimod leads to human dermal dendritic cell maturation and CD8(+) T-cell cross-priming

C.M. Fehres, S.C.M. Bruijns, A.J. van Beelen, H. Kalay, M. Ambrosini, E. Hooijberg, W.W.J. Unger, T.D. de Gruijl, Y. van Kooyk

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)2415-2424
JournalEuropean Journal of Immunology
Volume44
Issue number8
DOIs
Publication statusPublished - 2014

Cite this